|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
FY2020
12 months to Dec 31, 2020
|
FY2019
12 months to Dec 31, 2019
|
|
|---|---|---|---|---|---|
| Net revenue | |||||
| Cost of revenue | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Research and product development | |||||
| Selling, marketing, general and administrative | |||||
| Restructuring and other charges | |||||
| Impairment of long-lived assets | |||||
| Impairment of goodwill | |||||
| Amortization of intangible assets | |||||
| Total operating expenses | |||||
| Operating loss | |||||
| Interest income | |||||
| Interest expense, net | |||||
| Loss on extinguishment of debt | |||||
| Other expense, net | |||||
| Loss before income taxes | |||||
| Income tax provision | |||||
| Net loss | |||||
| Foreign currency translation adjustments | |||||
| Actuarial gain (loss) | |||||
| Comprehensive loss | |||||
| Net loss per share | |||||
| Basic | |||||
| Diluted | |||||
| Weighted average shares outstanding, basic | |||||
| Weighted average shares outstanding, diluted | |||||
Loading...